H.C. Wainwright keeps a Buy rating on Tenaya Therapeutics (TNYA) with a $5 price target after the company presented an interim update from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback